Risk of Hearing Loss in Neonates and Toddlers with in Utero Exposure to SARS ‐ CoV ‐2
The Laryngoscope · 2024
DOI: 10.1002/lary.31739 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Laryngoscope, 2024. Verfasst von Imaal Ahmed und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Columbia University Irving Medical Center, New York, NY, USA. Hauptthemen laut MEDLINE: COVID-19, Hearing Loss, Pregnancy Complications, Infectious, SARS-CoV-2. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIMH NIH HHS, Einhorn Collaborative, W.K. Kellogg Foundation.
Abstract (Originalsprache)
Objective
Given the prevalence of neonatal hearing loss (HL) associated with intrauterine viral exposures, the goal of this study is to provide information on neonatal HL in the context of the COVID‐19 pandemic.
Methods
Data were drawn from the COVID‐19 Mother Baby Outcomes (COMBO) Initiative. 1007 participants completed the newborn hearing screen as part of routine clinical care (COMBO‐EHR cohort) and 555 completed the National Survey of Children's Health (NSCH) at 2 and/or 3 years of age for research purposes (COMBO‐RSCH cohort). Maternal SARS‐CoV‐2 infection status during pregnancy was determined through electronic health records and maternal‐reported questionnaires.
Results
In adjusted multivariate logistic regression models covarying for newborn age at assessment, mode of delivery, and gestational age at delivery, there was no significant association between intrauterine SARS‐CoV‐2 exposure and newborn hearing screening failure ( OR = 1.05, 95% CI = 0.39–2.42, p = 0.91) in the COMBO‐EHR cohort. In the COMBO‐RSCH cohort, there were similar non‐significant associations between intrauterine exposure to SARS‐CoV‐2 and maternal‐reported concern for HL on the NSCH ( OR = 1.19 [95% CI = 0.30–4.24], p = 0.79).
Conclusion
There is no association between intrauterine exposure to SARS‐CoV‐2 and failed hearing screen in neonates. Similarly, based on the NSCH, there is no association between intrauterine exposure to SARS‐CoV‐2 and maternal‐reported concern for hearing in toddlers. These results offer reassurance given the widespread nature of this pandemic with tens of millions of fetuses having a history of intrauterine exposure. Level of Evidence Level 4 Laryngoscope , 2024
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pediatrics, Columbia University Irving Medical Center, New York, NY, USA.
- Department of Otolaryngology-Head & Neck Surgery, Columbia University Irving Medical Center, New York, NY, USA.
- Department of Psychiatry, Columbia University Irving Medical Center, New York, NY, USA.
- NewYork-Presbyterian, New York, NY, USA.
ORCID-Profile: Michelle Yu, Westin Mace
Förderung
- NIMH NIH HHS
- Einhorn Collaborative
- W.K. Kellogg Foundation
- National Institute of Mental Health
Zitieren
APA
Ahmed, I., Yu, M., Chaves, V., Xu, R., Lavallée, A., Warmingham, J. M., Firestein, M., Kyle, M. H., Fisher, K., Merriman, E. T., Rodriguez, C., Mace, W., Fernandez, C., Dumitriu, D., & Lalwani, A. K. (2024). Risk of Hearing Loss in Neonates and Toddlers with in Utero Exposure to SARS ‐ CoV ‐2. The Laryngoscope. https://doi.org/10.1002/lary.31739
Vancouver
Ahmed I, Yu M, Chaves V, Xu R, Lavallée A, Warmingham JM, et al. Risk of Hearing Loss in Neonates and Toddlers with in Utero Exposure to SARS ‐ CoV ‐2. The Laryngoscope. 2024. doi:10.1002/lary.31739
BibTeX
@article{Ahmed2024,
author = {Ahmed, Imaal and Yu, Michelle and Chaves, Vitoria and Xu, Ruiyang and Lavallée, Andréane and Warmingham, Jennifer M and Firestein, Morgan and Kyle, Margaret H and Fisher, Kaylee and Merriman, Emma T and Rodriguez, Cynthia and Mace, Westin and Fernandez, Cristina and Dumitriu, Dani and Lalwani, Anil K},
title = {Risk of Hearing Loss in Neonates and Toddlers with in Utero Exposure to SARS ‐ CoV ‐2},
journal = {The Laryngoscope},
year = {2024},
doi = {10.1002/lary.31739}
}
EUVIMED